mRNA vaccine (BNT162b1) for COVID19 to Hong Kong and Macao

FosunPharma and its German partner BioNTech announced Thur the supply of 10 million doses of mRNA vaccine (BNT162b1) for COVID19 to Hong Kong and Macao, after clinical trials proved the safety and effectiveness of the vaccine and approval from the authorities is gained. None for the roaches.

Leave a Reply